OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Matteo Morotti, Alizée J. Grimm, Helen Carrasco Hope, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 426-434
Open Access | Times Cited: 56

Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 26

KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection
Eric Fagerberg, John Attanasio, Christine Dien, et al.
Science (2025) Vol. 387, Iss. 6735
Closed Access | Times Cited: 2

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Zachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Nature (2025)
Open Access | Times Cited: 2

Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity
Jie Yang, Yumi Yamashita-Kanemaru, Benjamin I. Morris, et al.
Nature (2025)
Open Access | Times Cited: 2

LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses
Hieu Minh Ta, Dia Roy, Keman Zhang, et al.
Science Immunology (2024) Vol. 9, Iss. 95
Open Access | Times Cited: 14

Exploiting temporal aspects of cancer immunotherapy
Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 480-497
Closed Access | Times Cited: 13

CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer
Yuchen Li, Yinfeng Gu, Pengyue Yang, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 1-14
Open Access | Times Cited: 10

Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9

Cranioencephalic functional lymphoid units in glioblastoma
Celia Dobersalske, Laurèl Rauschenbach, Yichao Hua, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2947-2956
Open Access | Times Cited: 8

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects
Willem Van Der Byl, Simone Nüssing, Timothy J. Peters, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1324-1344.e8
Closed Access | Times Cited: 6

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 6

Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Inga-Maria Launonen, Erdoğan Pekcan Erkan, Iga Niemiec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy
Geoffrey J. Markowitz, Yi Ban, Diamile A. Tavarez, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1884-1899
Closed Access | Times Cited: 5

Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
Inga-Maria Launonen, Iga Niemiec, María Mercedes Hincapié-Otero, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2045-2063.e10
Closed Access | Times Cited: 4

Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access

Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
Catarina Gago da Graça, Amania A. Sheikh, Dane M. Newman, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access

Engineering cytokines for tumor-targeting and selective T cell activation
Kun Peng, Yang‐Xin Fu, Yong Liang
Trends in Molecular Medicine (2025)
Closed Access

T Cell Dysfunction in Cutaneous Leishmaniasis at Single-Cell Resolution
Jonathan Peña Avila, Youvika Singh, Fernando N. Souza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

T cell exhaustion: early or late in tumour progression?
Lorenzo Galluzzi
Nature reviews. Immunology (2025)
Closed Access

Effect of glioblastoma and brain radiotherapy on T-lymphocyte subpopulations in rodents
Thao-Nguyen Pham, Julie Coupey, Florian Yger, et al.
Radiotherapy and Oncology (2025) Vol. 206, pp. 110801-110801
Open Access

Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
Yanping Sun, Linling Zhou, Xinyu Gu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010140-e010140
Open Access

Page 1 - Next Page

Scroll to top